πŸ‡ΊπŸ‡Έ FDA
Patent

US 12077543

P2X3 and/or P2X2/3 compounds and methods

granted A61PA61P11/00A61P11/06

Quick answer

US patent 12077543 (P2X3 and/or P2X2/3 compounds and methods) held by Asana BioSciences, LLC expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P11/00, A61P11/06, A61P11/08, A61P25/00